ITTO20110640A1 - Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati al sistema cardiovascolare - Google Patents

Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati al sistema cardiovascolare

Info

Publication number
ITTO20110640A1
ITTO20110640A1 IT000640A ITTO20110640A ITTO20110640A1 IT TO20110640 A1 ITTO20110640 A1 IT TO20110640A1 IT 000640 A IT000640 A IT 000640A IT TO20110640 A ITTO20110640 A IT TO20110640A IT TO20110640 A1 ITTO20110640 A1 IT TO20110640A1
Authority
IT
Italy
Prior art keywords
methods
combination
pharmaceutical composition
cardiovascular system
states associated
Prior art date
Application number
IT000640A
Other languages
English (en)
Inventor
Liudmila Fyodorovna Dolgovyh
Oleg Iliich Epshtein
Vladmir Ivanovich Petrov
Svetlana Alexandrovna Sergeeva
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2010129290/15A external-priority patent/RU2525155C2/ru
Priority claimed from RU2010129292/15A external-priority patent/RU2523557C2/ru
Priority claimed from RU2010129291/15A external-priority patent/RU2525156C2/ru
Priority claimed from RU2011110106/15A external-priority patent/RU2523451C2/ru
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of ITTO20110640A1 publication Critical patent/ITTO20110640A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
IT000640A 2010-07-15 2011-07-15 Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati al sistema cardiovascolare ITTO20110640A1 (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
RU2010129290/15A RU2525155C2 (ru) 2010-07-15 2010-07-15 Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для комплексной терапии хронической сердечной недостаточности
RU2010129292/15A RU2523557C2 (ru) 2010-07-15 2010-07-15 Способ лечения вегетососудистой дистонии и фармацевтическая композиция для лечения вегетососудистой дистонии
RU2010129291/15A RU2525156C2 (ru) 2010-07-15 2010-07-15 Способ лечения и профилактики артериальной гипертензии и фармацевтическая композиция для лечения артериальной гипертензии
RU2011110106/15A RU2523451C2 (ru) 2011-03-17 2011-03-17 Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для лечения хронической сердечной недостаточности

Publications (1)

Publication Number Publication Date
ITTO20110640A1 true ITTO20110640A1 (it) 2012-01-16

Family

ID=44899163

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000640A ITTO20110640A1 (it) 2010-07-15 2011-07-15 Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati al sistema cardiovascolare

Country Status (23)

Country Link
US (1) US8703124B2 (it)
EP (1) EP2593482A2 (it)
JP (1) JP2013532183A (it)
KR (1) KR20140009110A (it)
AR (1) AR084707A1 (it)
AU (1) AU2011278039B2 (it)
BR (1) BR112013000779A2 (it)
CA (1) CA2804969A1 (it)
DE (1) DE112011102356T5 (it)
DK (1) DK201370080A (it)
EA (1) EA201300128A1 (it)
EE (1) EE201300004A (it)
FI (1) FI20135145A7 (it)
FR (1) FR2962654A1 (it)
GB (1) GB2496795A (it)
IT (1) ITTO20110640A1 (it)
MX (1) MX2013000544A (it)
NO (1) NO20130217A1 (it)
PH (1) PH12013500111A1 (it)
SE (1) SE1350177A1 (it)
SG (1) SG187034A1 (it)
UA (1) UA114699C2 (it)
WO (1) WO2012007846A2 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2201255C1 (ru) * 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
PH12013500107A1 (en) 2010-07-15 2013-03-11 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
EA029199B1 (ru) 2010-07-21 2018-02-28 Олег Ильич Эпштейн Комбинированная фармацевтическая композиция для лечения синдрома дефицита внимания и гиперактивности и способы лечения синдрома дефицита внимания и гиперактивности
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2201255C1 (ru) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
CA2518965C (en) 2003-03-14 2018-10-30 Nutrition Research Inc. Homeopathic formulations useful for treating pain and/or inflammmation
JP5239899B2 (ja) 2008-07-29 2013-07-17 株式会社リコー 画像形成装置

Also Published As

Publication number Publication date
BR112013000779A2 (pt) 2016-06-07
WO2012007846A2 (en) 2012-01-19
SE1350177A1 (sv) 2013-04-12
MX2013000544A (es) 2013-10-28
CA2804969A1 (en) 2012-01-19
FI20135145L (fi) 2013-02-15
FR2962654A1 (fr) 2012-01-20
NO20130217A1 (no) 2013-03-22
UA114699C2 (uk) 2017-07-25
KR20140009110A (ko) 2014-01-22
US8703124B2 (en) 2014-04-22
FI20135145A7 (fi) 2013-02-15
EE201300004A (et) 2013-08-15
GB2496795A (en) 2013-05-22
AU2011278039A1 (en) 2013-03-07
EP2593482A2 (en) 2013-05-22
AR084707A1 (es) 2013-06-05
US20120251584A1 (en) 2012-10-04
PH12013500111A1 (en) 2017-07-26
SG187034A1 (en) 2013-02-28
EA201300128A1 (ru) 2013-12-30
GB201302656D0 (en) 2013-04-03
JP2013532183A (ja) 2013-08-15
DK201370080A (en) 2013-02-14
WO2012007846A3 (en) 2012-04-12
AU2011278039B2 (en) 2015-07-23
DE112011102356T5 (de) 2013-04-18

Similar Documents

Publication Publication Date Title
HUE049880T2 (hu) Anyag és eljárások Her-3-mal összefüggõ betegségek kezelésére vagy megelõzésére
BR112013009069A2 (pt) instrumentação unida ao paciente e métodos
BR112012028573A2 (pt) sistema de treinamento de auscultação e métodos relacionados
ITTO20110628A1 (it) Composizione farmaceutica di combinazione e metodi per trattare patologie funzionali o stati patologici del tratto gastrointestinale
DK2544719T3 (da) Cd37-bindingsmolekyler og immunkonjugater deraf
PT2424896E (pt) Anticorpos anti-ceacam1 e métodos de utilização dos mesmos
PL3181134T3 (pl) Bifidobakterie do leczenia cukrzycy i stanów pokrewnych
BRPI0911669A2 (pt) sistema e métodos para o aperfeiçoamento da eficiência da disposição de orifício de catéter
SMT201600050B (it) Mezzi e metodi per trattare il dlbcl
BR112012012231A2 (pt) método e sistema
ITTO20110640A1 (it) Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati al sistema cardiovascolare
BR112013009965A2 (pt) "sistema e método"
BR112012022445A2 (pt) "sistema e mídia de aemazenagem
BR112012002301A2 (pt) método e sistema
ITTO20110638A1 (it) Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati a patologie o stati patologici respiratori
BRPI1006398A2 (pt) método e sistema
BRPI1010203A2 (pt) sistema e método
PL2621523T3 (pl) Sposoby leczenia choroby autoimmunologicznej z zastosowaniem biokompatybilnych bioabsorbowalnych nanosfer
BRPI1008270A2 (pt) aparelho e sistema
BR112012017067A2 (pt) método e sistema de associação rede-aplicativo
EP2465593A4 (en) METHOD OF TREATING WATER AND FLOCCULATING WATER TREATMENT
BR112012031201A2 (pt) disposição de suspensão e trilho
DK2260994T3 (da) Formsystem samt anvendelse deraf
EP2376915A4 (en) PROOF OF OLIGOSACCHARIDES
HUE042334T2 (hu) Szürkevíz kezelõ rendszer és eljárás